Procedure
Primary Tumor Resection
Primary Tumor Resection is a medical procedure with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Phase Distribution
Ph not_applicable
1
20%
Ph phase_2
1
20%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution2 total trials
Phase 2Efficacy & side effects
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Active(1)
Completed(3)
Other(1)
Detailed Status
Completed3
Not yet recruiting1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (50.0%)
N/A1 (50.0%)
Trials by Status
not_yet_recruiting120%
completed360%
unknown120%
Recent Activity
0 active trials
Showing 5 of 5
not_yet_recruitingnot_applicable
Surgery Plus Systemic Therapy for Liver Cancer With Extrahepatic Metastases
NCT07537959
completed
Survival Benefit of Primary Tumour Resection Compared to Systemic Therapy Alone in Stage IV Colorectal Cancer Patients
NCT06326619
unknown
Colonic Resection or Stoma, or Self-expandable Metallic Stent for obstruCtive Left cOlon Cancer
NCT05801211
completedphase_2
Protracted Etoposide During Induction Therapy for High Risk Neuroblastoma
NCT00578864
completed
Hepatic RFA Increases T Cell Infiltraion and PD-L1 Expression in Primary Colorecatl Cancer
NCT02475889
Clinical Trials (5)
Showing 5 of 5 trials
NCT07537959Not Applicable
Surgery Plus Systemic Therapy for Liver Cancer With Extrahepatic Metastases
NCT06326619
Survival Benefit of Primary Tumour Resection Compared to Systemic Therapy Alone in Stage IV Colorectal Cancer Patients
NCT05801211
Colonic Resection or Stoma, or Self-expandable Metallic Stent for obstruCtive Left cOlon Cancer
NCT00578864Phase 2
Protracted Etoposide During Induction Therapy for High Risk Neuroblastoma
NCT02475889
Hepatic RFA Increases T Cell Infiltraion and PD-L1 Expression in Primary Colorecatl Cancer
All 5 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 5